URAPIDIL KALCEKS süste-/infusioonilahus Eesti - eesti - Ravimiamet

urapidil kalceks süste-/infusioonilahus

kalceks as - urapidiil - süste-/infusioonilahus - 50mg 5tk

URAPIDIL KALCEKS süste-/infusioonilahus Eesti - eesti - Ravimiamet

urapidil kalceks süste-/infusioonilahus

kalceks as - urapidiil - süste-/infusioonilahus - 25mg 5tk

TACHYBEN infusioonilahuse kontsentraat Eesti - eesti - Ravimiamet

tachyben infusioonilahuse kontsentraat

ever neuro pharma gmbh - urapidiil - infusioonilahuse kontsentraat - 5mg 1ml 20ml 5tk

TACHYBEN süstelahus Eesti - eesti - Ravimiamet

tachyben süstelahus

ever neuro pharma gmbh - urapidiil - süstelahus - 5mg 1ml 10ml 5tk

TACHYBEN süstelahus Eesti - eesti - Ravimiamet

tachyben süstelahus

ever neuro pharma gmbh - urapidiil - süstelahus - 5mg 1ml 5ml 5tk

VIROPHTA silmatilgad, lahuse pulber ja lahusti Eesti - eesti - Ravimiamet

virophta silmatilgad, lahuse pulber ja lahusti

tubilux pharma s.p.a. - trifluridiin - silmatilgad, lahuse pulber ja lahusti - 1% 5ml 1tk

VIROPTIC silmatilgad, lahus Eesti - eesti - Ravimiamet

viroptic silmatilgad, lahus

dsm pharmaceuticals inc. - trifluridiin - silmatilgad, lahus - 1% 7.5ml 1tk

VIROPHTA silmatilgad, lahuse pulber ja lahusti Eesti - eesti - Ravimiamet

virophta silmatilgad, lahuse pulber ja lahusti

allergan pharmaceuticals ireland - trifluridiin - silmatilgad, lahuse pulber ja lahusti - 1% 5ml 1tk

Lonsurf Euroopa Liit - eesti - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil vesinikkloriid - kolorektaalne kasvaja - antineoplastilised ained - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Inaqovi Euroopa Liit - eesti - EMA (European Medicines Agency)

inaqovi

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukeemia, müeloid - antineoplastilised ained - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.